Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Viatris Inc | Chief Commercial Officer | Restricted Stock Units | 39.3K | $369K | $9.37 | Apr 15, 2025 | Direct |
Viatris Inc | Chief Commercial Officer | Common Stock | 35.3K | $362K | $10.25 | Sep 11, 2025 | Direct |
Celsion CORP | President and CEO, Director | Common Stock | 53K | $51.9K | $0.98 | Jul 18, 2022 | Direct |
Viatris Inc | Chief Commercial Officer | Dividend Equivalent Units | 1.77K | $16.6K | $9.37 | Apr 15, 2025 | Direct |
Imunon, Inc. | President and CEO, Director | Stock Option (Right to Buy) | 320K | Mar 17, 2023 | Direct | ||
Longboard Pharmaceuticals, Inc. | Director | Stock Option (Right to Buy) | 22.5K | May 23, 2024 | Direct | ||
Longboard Pharmaceuticals, Inc. | Director | Employee Stock Option (right to buy) | 0 | Dec 2, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
VTRS | Viatris Inc | Sep 11, 2025 | 1 | -$72K | 4 | Sep 12, 2025 | Chief Commercial Officer |
VTRS | Viatris Inc | Apr 15, 2025 | 6 | -$149K | 4 | Apr 16, 2025 | Chief Commercial Officer |
VTRS | Viatris Inc | Mar 6, 2025 | 1 | $0 | 4 | Mar 10, 2025 | Chief Commercial Officer |
VTRS | Viatris Inc | Mar 4, 2025 | 6 | -$157K | 4 | Mar 5, 2025 | Chief Commercial Officer |
LBPH | Longboard Pharmaceuticals, Inc. | Dec 2, 2024 | 5 | $0 | 4 | Dec 2, 2024 | Director |
LBPH | Longboard Pharmaceuticals, Inc. | May 23, 2024 | 1 | $0 | 4 | May 24, 2024 | Director |
VTRS | Viatris Inc | Apr 18, 2024 | 2 | $0 | 4 | Apr 19, 2024 | Chief Commercial Officer |
VTRS | Viatris Inc | Apr 15, 2024 | 0 | $0 | 3 | Apr 19, 2024 | Chief Commercial Officer |
LBPH | Longboard Pharmaceuticals, Inc. | May 25, 2023 | 1 | $0 | 4 | May 26, 2023 | Director |
IMNN | Imunon, Inc. | Mar 17, 2023 | 1 | $0 | 4 | Mar 21, 2023 | President and CEO, Director |
IMNN | Celsion CORP | Jul 18, 2022 | 2 | $0 | 4 | Jul 20, 2022 | President and CEO, Director |
IMNN | Celsion CORP | Jul 18, 2022 | 0 | $0 | 3 | Jul 20, 2022 | President and CEO, Director |
LBPH | Longboard Pharmaceuticals, Inc. | May 24, 2022 | 1 | $0 | 4 | May 31, 2022 | Director |